Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.62 |
| ▸ | CA2 | P00918 | 6/20 | 0.62 |
| ▸ | CA9 | Q16790 | 5/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodobenzene SCHEMBL2903524 | 0.89 | HTT (0.55) | CA1CA2CA9HTTCA5A | |
| SCHEMBL9085552 | 0.85 | CA12 (0.71) | CA1CA2CA9HTTCA12 | |
| SCHEMBL4362672 | 0.83 | CA1 (0.56) | CA1CA2CA9HTTCA5A | |
| SCHEMBL576035 | 0.82 | CA2 (0.50) | CA1CA2CA9HSD11B1 | |
| SCHEMBL4369189 | 0.82 | CA2 (0.54) | CA1CA2CA9HTTCA5A | |
| SCHEMBL3141207 | 0.81 | HSPB1 (0.44) | CA1CA2CA9HTTCA5A | |
| SCHEMBL11704991 | 0.81 | CA1 (0.67) | CA1CA2CA9HTTCA5A | |
| SCHEMBL17318171 | 0.81 | CA1 (0.67) | CA1CA2CA9HTTCA5A | |
| SCHEMBL866410 | 0.80 | CA1 (0.71) | CA1CA2CA9HTTCA5A | |
| SCHEMBL29832245 | 0.80 | PDE4A (0.55) | CA1CA2CA9HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4090654-B1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | LUPIN LTD (IN) | 2025-07-09 | — | — | EP | claimed |
| US-12344592-B2 | Methods, processes and intermediates for preparing chroman compounds | LUPIN LIMITED (IN) | 2025-07-01 | — | — | US | claimed |
| CN-114981253-B | Process and intermediates for preparing chroman compounds and methods therefor | 印度鲁宾有限公司 | 2024-06-18 | — | — | CN | claimed |
| EP-3613070-B1 | PHOTOPATTERNABLE FILM | UNIV CHICAGO (US) | 2023-10-18 | — | — | EP | claimed |
| CN-110832618-B | Photoactive inorganic ligand-capped inorganic nanocrystals | 芝加哥大学 | 2023-09-12 | — | — | CN | claimed |
| US-11720017-B2 | Photoactive, inorganic ligand-capped inorganic nanocrystals | THE UNIVERSITY OF CHICAGO (US) | 2023-08-08 | — | — | US | claimed |
| US-20230140054-A1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | LUPIN LIMITED (IN) | 2023-05-04 | — | — | US | claimed |
| EP-4090654-A1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | Lupin Limited (IN) | 2022-11-23 | — | — | EP | claimed |
| CN-114981253-A | Process and intermediates for preparing chroman compounds and methods therefor | 印度鲁宾有限公司 | 2022-08-30 | — | — | CN | claimed |
| WO-2022168122-A1 | PROCESSES FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6-DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2022-08-11 | — | — | WO | claimed |
| US-20180334464-A1 | Process for the Synthesis of Substituted Morphinans | JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT | 2018-11-22 | — | — | US | claimed |
| EP-2590649-A1 | PROCESS FOR THE SYNTHESIS OF SUBSTITUTED MORPHINANS | Alkermes Pharma Ireland Limited (IE) | 2013-05-15 | — | — | EP | claimed |
| EP-1937689-B1 | INTERMEDIATE AND PROCESS OF PREPARATION OF ECTEINASCIDINS SUCH AS ECTEINASCIDINS 583 AND 597 USING SUCH INTERMEDIATE | CENTRE NAT RECH SCIENT (FR) | 2012-04-18 | — | — | EP | claimed |
| WO-2012005795-A1 | PROCESS FOR THE SYNTHESIS OF SUBSTITUTED MORPHINANS | ALKERMES, INC. (US) | 2012-01-12 | — | — | WO | claimed |
| US-20090171080-A1 | Intermediate and Process of Preparation of Ecteinascidin Such as Ecteinascidines-583,597 Using Such Intermediate | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2009-07-02 | — | — | US | claimed |
| CN-100457713-C | Method for prudicing amino-diphenylamine | BAYER AG (DE) | 2009-02-04 | — | — | CN | claimed |
| EP-1937689-A2 | INTERMEDIATE AND PROCESS OF PREPARATION OF ECTEINASCIDIN SUCH AS ECTEINASCIDINES-583, 597 USING SUCH INTERMEDIATE | Centre National de la Recherche Scientifique (FR) | 2008-07-02 | — | — | EP | claimed |
| EP-1792904-A1 | Intermediate and process of preparation of ecteinascidin using such intermediate | Centre National de la Recherche Scientifique (CNRS) (FR) | 2007-06-06 | — | — | EP | claimed |
| WO-2007045686-A2 | INTERMEDIATE AND PROCESS OF PREPARATION OF ECTEINASCIDIN SUCH AS ECTEINASCIDINES-583, 597 USING SUCH INTERMEDIATE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2007-04-26 | — | — | WO | claimed |
| CN-1517332-A | Method for prudicing amino-diphenylamine | — | 2004-08-04 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230140054-A1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | CASR, CALCR, RYR1 | CA1 526/4885CA2 24/4885CA9 572/4885 |
| US-20180334464-A1 | Process for the Synthesis of Substituted Morphinans | CYP1B1, CYP2F1, CYP1A2 | CA1 1022/4885CA2 1214/4885CA9 1447/4885 |
| US-20090171080-A1 | Intermediate and Process of Preparation of Ecteinascidin Such as Ecteinascidines-583,597 Using Such Intermediate | MMP7, CCR7, AREG | CA1 3870/4885CA2 4422/4885CA9 4048/4885 |
| US-12344592-B2 | Methods, processes and intermediates for preparing chroman compounds | CASR, CALCR, RYR1 | CA1 526/4885CA2 24/4885CA9 572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.